Using AI to help prevent diabetic blindness.

Vitazi-DR enables screening for diabetic retinopathy 30 times faster than traditional methods with 95% accuracy, at lower cost and without need for special training.

 
 

Diabetic vision loss, or diabetic retinopathy, affects up to 80% of those who have had diabetes for 20 years or more.

Diabetic vision loss is the leading cause of blindness among working-aged adults around the world (estimated at 4 million).

Only half of all people with diabetes get an annual comprehensive eye exam.

With early detection, loss of vision can be avoided completely or, in the case of up to 95% patients with an advanced stage of the disease, halted.